Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $11 | $15 | $13 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $3 | $3 | $2 |
| Inventory | $1 | $0 | $1 | $0 |
| Other Curr. Assets | $2 | $1 | $0 | $1 |
| Total Curr. Assets | $20 | $15 | $18 | $16 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $1 | $1 | $1 |
| Intangibles | $31 | $53 | $54 | $106 |
| Long-Term Investments | $0 | $0 | $54 | -$1 |
| Tax Assets | $0 | $0 | $1 | $1 |
| Other NC Assets | $0 | $0 | -$54 | $0 |
| Total NC Assets | $34 | $56 | $58 | $109 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $53 | $71 | $76 | $126 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $2 |
| Short-Term Debt | $0 | $0 | $1 | $2 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $3 | $4 | $3 |
| Total Curr. Liab. | $5 | $5 | $7 | $7 |
| LT Debt | $2 | $2 | $2 | $2 |
| Deferred Rev, NC | $2 | $0 | $2 | $2 |
| Deferred Tax Liab, NC | $5 | $7 | $7 | $13 |
| Other NC Liab. | $3 | $8 | $8 | $9 |
| Total NC Liab. | $12 | $17 | $17 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $3 | $3 |
| Total Liabilities | $17 | $22 | $24 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $56 | $56 |
| Retained Earnings | -$236 | -$223 | -$218 | -$176 |
| AOCI | $1 | $271 | $6 | $222 |
| Other Equity | $270 | -$0 | $208 | -$7 |
| Total Equity | $37 | $49 | $52 | $94 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $53 | $71 | $76 | $126 |
| Net Debt | -$13 | -$9 | -$12 | -$8 |